调解效应分析:虚弱如何影响患有缺血性中风的老年患者的跌倒恐惧和跌倒风险
Mingjie Chen1, Zhenhui Pan2, Chuanhang Lin2
1Zhaoqing First People's Hospital, Zhaoqing City, Guangdong Province, China.
Medicine
|October 7, 2025
概括
脆弱性显著增加了老年缺血性中风患者的跌倒风险. 害怕跌倒的行为作为一个调解者,更大的脆弱导致增加的恐惧,提高跌倒的风险. 干预措施应应对身体虚弱和对跌倒的恐惧.
科学领域:
- 老年学是一门学科.
- 神经学 神经学
- 公共卫生 公共卫生
背景情况:
- 患有缺血性中风的老年患者面临高跌倒风险,影响他们的生活质量.
- 脆弱和害怕跌倒被认为是导致老年人跌倒风险的重要因素.
研究的目的:
- 调查老年缺血性中风患者中跌倒恐惧在脆弱性和跌倒风险之间的关系中的调解作用.
- 在这个人群中分析脆弱性,跌倒恐惧和跌倒风险之间的关联和途径.
主要方法:
- 一项涉及280名老年缺血性中风患者的横截面研究.
- 使用的验证尺度:老年人跌倒风险自我评估,修改后跌倒有效性尺度 (MFES),蒂尔堡脆弱性指标 (TFI),医院焦虑和抑郁量表 (HADS) 和家庭APGAR指数.
- 采用皮尔森相关性,单变量分析和多重线性回归来进行数据分析.
主要成果:
- 虚弱与跌倒风险增加有着强烈而积极的关联 (R=0.886,P<0.001).
- 跌倒的恐惧与跌倒风险有显著的负相关性 (r=-0.834,P<0.001),这表明通过避免行为具有保护作用.
- 年龄是增加跌倒风险的重要预测因素,而运动和辅助设备减少了风险.
结论:
- 脆弱性显著提高了老年缺血性中风幸存者的跌倒风险.
- 跌倒的恐惧部分介绍了脆弱和跌倒风险之间的关系.
- 临床干预应同时解决身体虚弱和心理因素,如害怕跌倒,以改善患者的安全和生活质量.
相关概念视频
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
187
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
187
01:15Drug Dosing: Geriatric Patients
225
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
225
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
196
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
196
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
234
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
234
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
232
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
232